REIC/Dkk-3 Gene Therapy Induces Immunogenic Cell Death in a Mouse Model of Malignant Mesothelioma

Anticancer Res. 2021 Oct;41(10):4837-4855. doi: 10.21873/anticanres.15298.

Abstract

Background/aim: The adenovirus vector- carrying reduced expression in immortalized cell (REIC) gene (Ad-REIC) increases endoplasmic reticulum stress chaperone GRP78/BiP expression and induces the JNK-mediated apoptotic pathway. We aimed to determine whether Ad-REIC-induced apoptotic cell death can trigger immunogenic cell death (ICD).

Materials and methods: We examined the emission of damage-associated molecular patterns in vitro and the vaccination effect in vivo. We determined the immunological changes in the tumour microenvironment by putative ICD inducers and the combined effects of immune checkpoint blockade therapies.

Results: Ad-REIC induced the release of high-mobility group box 1 and adenosine triphosphate and the translocation of calreticulin in murine mesothelioma AB12 cells. The vaccination effect was elicited by Ad-REIC treatment in vivo. The effect of Ad-REIC was potentiated by anti-cytotoxic T-lymphocyte-associated protein 4 antibody treatment in a murine mesothelioma AB1-HA cell model.

Conclusion: Ad-REIC induces ICD in malignant mesothelioma.

Keywords: REIC; adenovirus vector; anti-cancer immunity; gene therapy; immune checkpoint inhibitors; immunogenic cell death.

MeSH terms

  • Adaptor Proteins, Signal Transducing / administration & dosage*
  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / immunology
  • Adenosine Triphosphate / metabolism
  • Adenoviridae / genetics
  • Animals
  • Apoptosis / drug effects
  • CD8 Antigens / metabolism
  • Calreticulin / metabolism
  • Cancer Vaccines / administration & dosage*
  • Cancer Vaccines / genetics
  • Cancer Vaccines / immunology
  • Combined Modality Therapy
  • Endoplasmic Reticulum Chaperone BiP
  • Genetic Therapy
  • Genetic Vectors
  • HMGB1 Protein / metabolism
  • Humans
  • Immune Checkpoint Inhibitors / immunology
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immunogenic Cell Death / drug effects*
  • Mesothelioma, Malignant / immunology
  • Mesothelioma, Malignant / therapy*
  • Mice
  • Tumor Microenvironment / drug effects
  • Tumor Microenvironment / immunology
  • Xenograft Model Antitumor Assays

Substances

  • Adaptor Proteins, Signal Transducing
  • CD8 Antigens
  • Calreticulin
  • Cancer Vaccines
  • DKK3 protein, human
  • Endoplasmic Reticulum Chaperone BiP
  • HMGB1 Protein
  • HMGB1 protein, mouse
  • HSPA5 protein, human
  • Hspa5 protein, mouse
  • Immune Checkpoint Inhibitors
  • Adenosine Triphosphate